1.Calcific Amyloidoma of Tibialis Anterior Muscle: Case Report.
Byung Ki CHO ; Yong Min KIM ; Dong Soo KIM ; Eui Sung CHOI ; Hyun Chul SHON ; Kyung Jin PARK ; Hu Shan CUI ; Seok Won KIM ; Ok Jun LEE
The Journal of the Korean Orthopaedic Association 2008;43(3):374-378
Calcific amyloidoma of the soft tissue is quite rare and it is difficult to make a differential diagnosis from other lesions such as osteomyelitis or bone tumor. We encountered a case of a calcified amyloidoma found in the anterior tibial muscle that occurred more than 20 years after a proximal tibial fracture adjacent to the origin of the muscle. The features of the lesion resembled osteomyelitis. Satisfactory result was obtained by a thorough mass excision. We report this case with review of the relevant literature.
Diagnosis, Differential
;
Muscle, Skeletal
;
Muscles
;
Osteomyelitis
;
Tibial Fractures
2.The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab.
Ji Young YUN ; Byung Hwa HYUN ; Sang Yoon NAM ; Young Won YUN ; Hu Jang LEE ; Beom Jun LEE
Laboratory Animal Research 2018;34(1):30-36
This study investigated the anti-cancer potential of a near-infrared fluorescence (NIRF) molecule conjugated with Cetuximab (Cetuximab-NIRF) in six-week-old female BALB/c athymic (nu+/nu+) nude mice. A431 cells were cultured and injected into the animals to induce solid tumors. Paclitaxel (30 mg/kg body weight (BW)), Cetuximab (1 mg/kg BW), and Cetuximab-NIRF (0.25, 0.5 and 1.0 mg/kg BW) were intraperitoneally injected twice a week into the A431 cell xenografts of the nude mice. Changes in BW, tumor volume and weight, fat and lean mass, and diameter of the peri-tumoral blood vessel were determined after two weeks. Tumor volumes and weights were significantly decreased in the Cetuximab-NIRF (1 mg/kg BW) group compared with the control group (P < 0.001). Lean mass and total body water content were also conspicuously reduced in the Cetuximab-NIRF (1 mg/kg BW) group compared with the vehicle control group. Peri-tumoral blood vessel diameters were very thin in the Cetuximab-NIRF groups compared with those of the paclitaxel group. These results indicate that the conjugation of Cetuximab with NIRF does not affect the anti-cancer potential of Cetuximab and NIRF can be used for molecular imaging in cancer treatments.
Animals
;
Blood Vessels
;
Body Water
;
Body Weight
;
Cetuximab*
;
Female
;
Fluorescence*
;
Heterografts
;
Humans
;
Mice
;
Mice, Nude
;
Molecular Imaging
;
Paclitaxel
;
Tumor Burden
;
Weights and Measures
3.A Case of Sarcomatoid Hepatocellular Carcinoma in a Young Female without Risk Factor.
Hyo Sung NAM ; Hae Kyung KIM ; Sae Ung MA ; Byung Hyun YU ; Ki Myung JUNG ; Kyung Taek GONG ; Yong Ju LEE ; Tae Il PARK ; Byung Won HU ; Shin Hee PARK ; Jin Yung NA ; Jin Uk CHOI ; Ho Jung KIM ; Uen Sil YU
The Korean Journal of Gastroenterology 2006;47(6):458-462
A previously healthy 22-year-old woman was admitted with a complaint of right upper quadrant abdominal pain for 2 weeks. Her past history was not remarkable. On admission, HBsAg and anti-HCV were negative and alpha-FP was within normal range. Abdominal sonography and CT showed a mass in liver measuring 10 11 cm with features of central necrosis and hemorrhage. On 6th hospital day, hemoperitoneum developed suddenly. She underwent emergency laparotomy and trisegmentectomy. Intraoperative finding revealed a hemoperitoneum with a tumor filled with liquefied necrotic tissues. Microscopically, the tumor was mostly composed of pleomorphic spindle cells with abundant anastomosing vascular channels and partly composed of tumor cells with trabecular arrangement. On immunohistochemical staining, tumor cells reacted with cytokeratin and vimentin, while CD34 and hepatocyte staining revealed negative. She died 2 months after the operation. We report a case of rapidly deteriorated primary sarcomatoid hepatocellular carcinoma in a young female without any risk factor.
Adult
;
Carcinoma, Hepatocellular/diagnosis/*pathology
;
Female
;
Humans
;
Liver Neoplasms/diagnosis/*pathology
;
Sarcoma/diagnosis/*pathology